| Primary |
| Postoperative Care |
10.8% |
| Prophylaxis |
10.8% |
| Psychotic Disorder |
10.8% |
| Systemic Lupus Erythematosus |
9.8% |
| Product Used For Unknown Indication |
6.9% |
| Gastritis |
5.9% |
| Hypertension |
5.9% |
| Rheumatoid Arthritis |
4.9% |
| Anaesthesia Procedure |
3.9% |
| Constipation |
3.9% |
| Deafness |
3.9% |
| Hyperlipidaemia |
2.9% |
| Insomnia |
2.9% |
| Lymphadenitis |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.9% |
| Prostate Cancer Metastatic |
2.9% |
| Back Pain |
2.0% |
| Chemotherapy |
2.0% |
| Enteritis Infectious |
2.0% |
| Fungal Infection |
2.0% |
|
| Intentional Drug Misuse |
15.4% |
| Dementia |
7.7% |
| Drug Eruption |
7.7% |
| Electrocardiogram Qt Prolonged |
7.7% |
| Anaphylactic Shock |
3.8% |
| Blood Pressure Increased |
3.8% |
| Cerebral Haemorrhage |
3.8% |
| Cerebrovascular Accident |
3.8% |
| Clostridium Difficile Colitis |
3.8% |
| Drug Ineffective |
3.8% |
| Drug-induced Liver Injury |
3.8% |
| Erythema Multiforme |
3.8% |
| Hypotension |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Laryngeal Obstruction |
3.8% |
| Macular Fibrosis |
3.8% |
| Off Label Use |
3.8% |
| Orbital Apex Syndrome |
3.8% |
| Papule |
3.8% |
| Prostate Cancer |
3.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.1% |
| Hypertension |
14.1% |
| Prophylaxis |
7.9% |
| Gastritis |
6.9% |
| Rheumatoid Arthritis |
5.8% |
| Gastric Ulcer |
4.0% |
| Immunosuppressant Drug Therapy |
3.9% |
| Osteoporosis |
3.9% |
| Epilepsy |
3.3% |
| Hepatitis B |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Febrile Neutropenia |
2.8% |
| Hyperlipidaemia |
2.8% |
| Myocardial Infarction |
2.6% |
| Cardiac Failure |
2.3% |
| Cardiac Failure Congestive |
2.3% |
| Thrombosis Prophylaxis |
1.9% |
| Coronary Arterial Stent Insertion |
1.8% |
| Atrial Fibrillation |
1.6% |
| Crohn's Disease |
1.6% |
|
| Stevens-johnson Syndrome |
17.5% |
| Interstitial Lung Disease |
13.8% |
| Pyrexia |
10.0% |
| Blood Alkaline Phosphatase Increased |
5.0% |
| Tuberculous Pleurisy |
5.0% |
| Hepatitis Acute |
3.8% |
| Liver Disorder |
3.8% |
| Platelet Count Decreased |
3.8% |
| Pneumothorax |
3.8% |
| Renal Impairment |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Urticaria |
3.8% |
| Viith Nerve Paralysis |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Drug Eruption |
2.5% |
| Erythema Multiforme |
2.5% |
| Henoch-schonlein Purpura |
2.5% |
| Hepatic Function Abnormal |
2.5% |
| Leukopenia |
2.5% |
| Multi-organ Failure |
2.5% |
|
| Concomitant |
| Prophylaxis |
15.5% |
| Hypertension |
12.7% |
| Rheumatoid Arthritis |
12.2% |
| Product Used For Unknown Indication |
8.1% |
| Gastritis |
7.2% |
| Constipation |
5.6% |
| Drug Use For Unknown Indication |
5.2% |
| Chronic Hepatitis C |
5.0% |
| Insomnia |
3.8% |
| Gastric Ulcer |
3.3% |
| Cancer Pain |
3.2% |
| Diabetes Mellitus |
2.9% |
| Pain |
2.7% |
| Gastritis Prophylaxis |
2.3% |
| Osteoporosis |
2.1% |
| Hyperlipidaemia |
1.7% |
| Crohn's Disease |
1.7% |
| Nausea |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Metastatic Renal Cell Carcinoma |
1.5% |
|
| White Blood Cell Count Decreased |
16.2% |
| Pyrexia |
9.0% |
| Vomiting |
7.8% |
| Interstitial Lung Disease |
6.1% |
| Platelet Count Decreased |
6.1% |
| Renal Impairment |
6.1% |
| Pneumonia |
5.7% |
| Rash |
5.6% |
| Renal Failure Acute |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Sepsis |
3.9% |
| Stomatitis |
3.3% |
| Liver Disorder |
3.0% |
| Urinary Tract Infection |
3.0% |
| Hepatic Function Abnormal |
2.8% |
| Nausea |
2.6% |
| Renal Disorder |
2.6% |
| Drug Eruption |
2.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.5% |
| Pneumocystis Jiroveci Pneumonia |
2.4% |
|
